Prediction: This Will Be Vertex Pharmaceuticals’ New Billion-Dollar Growth Driver (and It’s Coming Soon).

Vertex Pharmaceuticals (NASDAQ: VRTX) transformed the world of cystic fibrosis (CF) treatment when it launched its first product for the disease 12 years ago. Since then, it’s built a CF treatment empire, including a portfolio of products that actually address the underlying caus

admin